Lung cancer is a malignant tumor with high incidence. Targeted therapy has gradually become the main treatment in recent years, and has shown significant results in delaying the disease and improving the quality of life of patients.
I. Status and Efficiency
of Targeted Therapy in Lung Cancer Treatment The importance of
targeted therapy in the treatment of lung cancer is self-evident. It prevents the growth and spread of cancer cells by specifically acting on specific molecules in cancer cells. Compared with traditional chemotherapy, targeted therapy shows significant advantages in improving the survival rate and quality of life of patients. Especially for patients with advanced or metastatic lung cancer, targeted drugs can significantly prolong the survival time without disease activity. Molecular targeted drugs, such as tyrosine kinase inhibitors, work mainly by inhibiting key enzymes in cancer cells, which can minimize the damage to normal cells and reduce the systemic side effects caused by traditional treatments. In addition, targeted therapy can also be combined with gene detection, according to the specific gene mutations in patients with individualized medication, thereby improving the accuracy and effectiveness of treatment, significantly improving the quality of life of patients. Therefore, targeted therapy has gradually become one of the mainstream methods in the field of lung cancer treatment, bringing hope of cure and improvement of quality of life for countless patients.
2. Common adverse reactions and treatment methods
in targeted therapy Common adverse reactions
in lung cancer patients receiving targeted therapy include rash, gastrointestinal problems and abnormal liver function. Rash is the most common skin side effect of targeted therapy, usually manifested as erythema, papules, blisters and other phenomena. Its formation mechanism is mainly due to the action of drugs on skin epidermal cells, which can be alleviated by topical drugs, emollients and avoiding irritants. Gastrointestinal problems such as diarrhea, nausea and vomiting are common in the early stage of targeted therapy, which may be due to the influence of drugs on the normal function of gastrointestinal tract, including appropriate diet regulation, use of antiemetics and anti-diarrhea drugs. Abnormal liver function is another common adverse reaction. Because of the burden on the liver caused by drug metabolism, patients need to monitor liver function indicators regularly, adjust the dosage or suspend treatment if necessary. In addition, more targeted treatment measures can be taken to minimize the occurrence of adverse reactions, so as to improve the treatment compliance and quality of life of patients.
3. Difficulties and impacts
of patients’ access to targeted drugs
Lung cancer patients often face multiple challenges such as insufficient drug supply, limited medical resources and heavy economic burden when obtaining targeted drugs. The high price of drugs has also greatly changed the family’s economic situation and increased the economic pressure of patients’treatment. The support of family members plays a key role in the treatment compliance of patients. Understanding and supporting patients to take medicine on time and ensuring the continuity of treatment can significantly improve the treatment effect. By rationally adjusting family economic expenditure, enhancing awareness of disease and treatment, and coordinating family affairs, family members can alleviate the psychological pressure and financial burden of patients to a large extent. Strengthen the reserve and supply of targeted drugs, and implement more preferential drug reimbursement policies to ensure that patients can get the treatment they need steadily.
Targeted therapy can effectively improve the survival rate and quality of life of patients with lung cancer, but its common adverse reactions and difficulties in obtaining them need to be paid attention to. Through scientific treatment of adverse reactions and improvement of drug supply, the treatment compliance and quality of life of patients will be greatly improved, and more patients will be brought hope for rehabilitation.
